Security key
928661107
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)
CUSIP: 928661107
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 159,533,673
- Total 13F shares
- 22,375,280
- Share change
- +6,232,402
- Total reported value
- $4,519,308
- Price per share
- $0.20
- Number of holders
- 31
- Value change
- +$1,221,435
- Number of buys
- 19
- Number of sells
- 9
Report period
Q1 2026
Institutions
31
Top holders
10
VNRX full security history
Previous quarter: Q4 2025
VOLITIONRX LTD SEC filings
VOLITIONRX LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 928661107
Recent filing periods:
Top shareholders of VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. |
13F
13D/G
|
Company |
11%
from 13D/G
|
11,463,603
|
$2,930,097 | — | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
5%
|
6,449,635
|
$1,612,409 | -$732,698 | 31 Dec 2025 | |
| Rodney Gerard Rootsaert |
3/4/5
|
Secretary |
0.8%
|
1,281,711
|
$307,610 | — | 17 Mar 2026 | |
| Terig Hughes |
3/4/5
|
Chief Financial Officer |
0.43%
|
684,970
|
$171,242 | — | 26 Feb 2026 | |
| Jacob Vincent Micallef |
3/4/5
|
Chief Scientific Officer |
0.42%
|
665,292
|
$159,669 | — | 17 Mar 2026 | |
| Jasmine Kway |
3/4/5
|
CEO - Singapore Volition |
0.27%
|
429,014
|
$107,253 | — | 26 Feb 2026 | |
| Nicholas Plummer |
3/4/5
|
GC - Volition Diagnostics |
0.26%
|
407,267
|
$97,744 | — | 17 Mar 2026 | |
| Salvatore Thomas Butera |
3/4/5
|
CEO - Volition Veterinary |
0.24%
|
375,203
|
$95,901 | — | 22 Jan 2026 | |
| Gael Forterre |
3/4/5
|
Chief Commercial Officer |
0.23%
|
368,838
|
$88,521 | — | 17 Mar 2026 | |
| Ann-Louise Batchelor |
3/4/5
|
Group Chief Marketing Officer |
0.22%
|
353,478
|
$88,369 | — | 26 Feb 2026 | |
| Kim Nguyen |
3/4/5
|
Director |
0.21%
|
336,372
|
$84,093 | — | 26 Feb 2026 | |
| Gaetan Michel |
3/4/5
|
Chief Operating Officer |
0.16%
|
256,746
|
$166,371 | — | 04 Oct 2025 | |
| Ethel Rubin |
3/4/5
|
Director |
0.16%
|
252,948
|
$63,237 | — | 26 Feb 2026 | |
| Andrew Retter |
3/4/5
|
Chief Medical Officer |
0.09%
|
146,568
|
$63,610 | — | 01 Nov 2025 | |
| Phillip Barnes |
3/4/5
|
Director |
0.04%
|
67,368
|
$17,219 | — | 22 Jan 2026 | |
| Mickie Henshall |
3/4/5
|
Director |
0.03%
|
44,206
|
$11,299 | — | 22 Jan 2026 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.96%
|
1,530,048
|
$391,692 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
963,986
|
$246,436 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.28%
|
445,187
|
$113,790 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
311,538
|
$79,629 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
259,593
|
$66,352 | — | 31 Dec 2025 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
0.16%
|
249,282
|
$63,716 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.11%
|
167,730
|
$42,872 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
134,668
|
$34,421 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
111,419
|
$28,479 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.07%
|
108,581
|
$28,000 | — | 31 Dec 2025 | |
| Warberg Asset Management LLC |
13F
|
Company |
0.06%
|
90,833
|
$23,162 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
56,834
|
$14,527 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
55,596
|
$14,210 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
50,000
|
$12,780 | — | 31 Dec 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.03%
|
39,999
|
$10,224 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
25,300
|
$6,467 | — | 31 Dec 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.01%
|
20,550
|
$5,253 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
15,956
|
$4,078 | — | 31 Dec 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
14,595
|
$3,730 | — | 31 Dec 2025 | |
| Creative Planning |
13F
|
Company |
0.01%
|
12,834
|
$3,280 | — | 31 Dec 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.01%
|
11,999
|
$3,384 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
960
|
$245 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
665
|
$170 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
430
|
$110 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
310
|
$79 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
265
|
$68 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
117
|
$30 | — | 31 Dec 2025 | |
| Eight Corp Ltd |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
24,030,664
mixed-class rows
|
$20,785,825 | — | 02 Jan 2024 | |
| Martin Charles Faulkes |
3/4/5
|
Executive Director, Director |
—
class O/S missing
|
2,096,207
|
$1,739,852 | — | 24 Jan 2024 | |
| Cameron John Reynolds |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
4,267,341
mixed-class rows
|
$1,039,334 | +$130,358 | 26 Feb 2026 | |
| Guy Archibald Innes |
3/4/5
|
Director |
—
mixed-class rows
|
3,414,127
mixed-class rows
|
$829,492 | +$109,810 | 26 Feb 2026 | |
| Timothy I. Still |
3/4/5
|
Director |
—
mixed-class rows
|
1,673,534
mixed-class rows
|
$415,467 | +$24,519 | 22 Jan 2026 | |
| Edward Futcher |
3/4/5
|
Director |
—
class O/S missing
|
436,436
|
$362,242 | — | 24 Jan 2024 | |
| Alan Colman |
3/4/5
|
Director |
—
mixed-class rows
|
282,364
mixed-class rows
|
$65,782 | — | 22 Jan 2026 |
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q1 2026
As of 31 Mar 2026,
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,375,280 shares.
The largest 10 holders included
Lagoda Investment Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, LUMINUS MANAGEMENT LLC, STATE STREET CORP, VANGUARD FIDUCIARY TRUST CO, BlackRock, Inc., NORTHERN TRUST CORP, Silverberg Bernstein Capital Management LLC, and Wealthspire Advisors, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
28
Q1 2026 holders
31
Holder diff
3
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.